ITAB

pharmaceuticals, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, B-cell disorders, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intraperitoneal, intra-muscular and aerosol therapies